Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
20.17
+0.30 (1.51%)
At close: Apr 24, 2025, 4:00 PM
19.88
-0.29 (-1.44%)
Pre-market: Apr 25, 2025, 7:03 AM EDT

Beam Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2017 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Market Capitalization
1,9621,9742,1592,6925,3274,611
Upgrade
Market Cap Growth
-8.58%-8.58%-19.78%-49.47%15.54%-
Upgrade
Enterprise Value
1,2721,2101,3181,7764,5394,443
Upgrade
Last Close Price
20.1724.8027.2239.1179.6981.64
Upgrade
PS Ratio
26.1431.085.7244.18102.75192105.00
Upgrade
PB Ratio
2.232.692.203.676.4418.77
Upgrade
P/TBV Ratio
2.672.692.203.676.4418.77
Upgrade
P/OCF Ratio
---119.48--
Upgrade
EV/Sales Ratio
20.0319.053.4929.1587.56185109.63
Upgrade
Debt / Equity Ratio
0.220.220.180.250.180.44
Upgrade
Asset Turnover
0.050.050.270.040.050
Upgrade
Quick Ratio
4.674.675.794.825.932.93
Upgrade
Current Ratio
4.824.825.894.895.963.01
Upgrade
Return on Equity (ROE)
-43.94%-43.94%-15.46%-37.06%-69.13%-112.32%
Upgrade
Return on Assets (ROA)
-20.26%-20.26%-7.88%-15.02%-15.41%-27.30%
Upgrade
Return on Capital (ROIC)
-25.35%-25.35%-10.67%-22.40%-22.36%-34.19%
Upgrade
Earnings Yield
-19.20%-19.09%-6.14%-10.74%-6.96%-4.22%
Upgrade
FCF Yield
-18.16%-18.05%-8.47%-0.98%-2.12%-2.43%
Upgrade
Buyback Yield / Dilution
-6.69%-6.69%-10.19%-9.01%-37.44%-621.24%
Upgrade
Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q